Lumicell Expands Engagement at ASBrS 2026 Annual Meeting
Lumicell showcased its expanded presence at the American Society of Breast Surgeons (ASBrS) 2026 Annual Meeting, featuring technology demonstrations, scientific data presentations, and clinical discussions aimed at enhancing intraoperative breast cancer detection. The company highlighted its LumiSystem for illuminating residual cancer in lumpectomy procedures and supported educational programs for surgical fellows. Lumicell remains committed to advancing cancer detection technologies and engaging with the breast surgery community.
SEATTLE, May 1, 2026 /PRNewswire/ — Lumicell, a leader in intraoperative fluorescence imaging technology for breast cancer surgery, announced today its expanded presence at the American Society of Breast Surgeons (ASBrS) 2026 Annual Meeting, taking place April 29–May 3, 2026, at the…